Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Veritone to Hold Second Quarter 2026 Results Conference Call on August 13th
-
Invicti Launches Agentic Pentest to Transform Modern Penetration Testing
-
Operation HOPE’s Latest HOPE Insider Survey Reveals More Than Three-Quarters of Respondents Say the Economy Is Not Working for Them
-
Gravie Appoints Former Optum Executive Eric Murphy to Board of Directors, Announces Funding Round Led by General Atlantic
-
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
-
Leidos and CoreWeave Collaborate to Accelerate Delivery of AI Capabilities for Defense, National Security and Intelligence Missions
-
Elastic and OpenAI Collaborate to Bring Frontier Intelligence to Unstructured Enterprise Data
-
Veolia Expands in Energy for Data Centers in the U.S., Selected to Operate a 350-MW Grid-Independent Microgrid
-
VantageScore 4.0, the Most Advanced Credit Score in the Mortgage Market, Now Integrated into Optimal Blue
-
Puerto Rico Distillery Opens in Historic Brunswick Building with Special Release Clandestino
-
Milliman analysis: Public pension funded ratio slips to 88.7% as of June 30
-
Patrick Industries, Inc. Reports Second Quarter 2026 Financial Results
-
Antora Closes $550 Million in Series C Funding to Meet Surging Energy Demand and Reindustrialize America
-
Piper Sandler Companies Reports Second Quarter 2026 Results; Declares Quarterly Dividend of $0.20 Per Share
-
Pantheon Closes Its Largest-Ever Co-Investment Program at $3.2 Billion
-
LPT Aperture Holdings Confidentially Submits Draft Registration Statement to the SEC for Proposed IPO
-
Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia
-
Transect Selected to Present at White House CEQ Permitting Innovators Expo
-
Avetta Research Illuminates Gap Between Increasing Supply Chain Risk and Organizational Readiness to Respond
-
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
-
Stride Announces CEO Succession
-
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
-
Rectitude Holdings Ltd Announces Full-Year Financial Results for the Fiscal Year Ended March 31, 2026
-
CorVascular Launches ASUS Handheld Ultrasound Portfolio for Vascular Specialists at SVU 2026
-
Colossal Raises $6.8M to Support The Art of Elysium, Reveals Inaugural People's Artist Winner
-
ZenaTech's DaaS Oil and Gas Business Enters a Strengthened Market with Higher Oil Prices and More Than US$500 Billion in Expected Canadian Energy Investment Over the Next Decade
-
Nautilus Solar and TurningPoint Energy Energize Second of Six Delaware Community Solar Projects
-
Immutep Quarterly Activities Report Q4 FY26
-
Capital IP Investment Partners Announces Strategic Investment in Minno
-
GigaCloud Technology Inc to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
-
Oyster Creek’s License Termination Plan Approved by the USNRC; Oyster Creek Project Planned to Feature Four SMR-300 Units
-
MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients
-
Aduro Secures Uinta Basin Crude Supply and Completes Continuous-Flow Unit, Advancing Paraffinic Crude Program to Technology Demonstration
-
SuperPower and Ever.green turned gamers into a clean energy buyer class
-
License Global Releases 2026 Top Global Licensors Whitepaper, Featuring Disney, Authentic Brands Group, People Inc.
-
Dynamix Capital Partners and Consortium Announces Closing of $95 Million Batch Zero Financing Fund to Unlock Grid Power for Texas Data Center Sites
-
Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update
-
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
-
Uniti Group Inc. Reports Second Quarter 2026 Results
-
Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
-
Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026
-
Ramaco Resources, Inc. to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 and Host Conference Call and Webcast on Wednesday, August 5
-
Rocket Doctor Extends EngageWell Partnership to Improve Healthcare Access for Underserved New Yorkers
-
Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin
-
Labrynth to Showcase AI-Enabled Permitting Technology at The White House Council on Environmental Quality Permitting Innovators Expo
-
Aureus Greenway Holdings Inc. and Autonomous Power Corporation (dba Powerus) Announce Public Filing of Form S-4 Registration Statement with the SEC
-
Diginex Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Exyn Technologies Demonstrates Power of Autonomous Mining with Major Productivity Gains at Eldorado Gold's Tüprag Mine in Turkey
-
Abercrombie & Fitch Returns to its New York Roots with Fall Denim Campaign
-
Innventure to Announce Second Quarter 2026 Results on August 13, 2026
